End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30/20/30 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 46 | 08/11 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/20/01 |
John McHutchison
BRD | Director/Board Member | 66 | 06/19/06 |
Shannon Ryan
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 01/19/01 | |
General Counsel | - | 01/22/01 | |
Nicole White
PRN | Corporate Officer/Principal | 44 | 17/20/17 |
Human Resources Officer | - | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 59 | 14/17/14 |
Gina Consylman
BRD | Director/Board Member | 52 | 20/20/20 |
William Ringo
CHM | Chairman | 78 | 01/14/01 |
Anthony Altig
BRD | Director/Board Member | 68 | 01/12/01 |
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30/20/30 |
Michael Houghton
BRD | Director/Board Member | 73 | 19/21/19 |
John McHutchison
BRD | Director/Board Member | 66 | 06/19/06 |
Tomas Cihlar
BRD | Director/Board Member | 57 | 07/12 |
Director/Board Member | 60 | 20/21/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,513,308 | 3,690,474 ( 66.94 %) | 0 | 66.94 % |
Company contact information
Assembly Biosciences, Inc.
Two Tower Place 7th floor
94080, South San Francisco
+833 509 4583
http://www.assemblybio.comSector
1st Jan change | Capi. | |
---|---|---|
+15.09% | 74.45B | |
+11.35% | 9.18B | |
+54.35% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-20.85% | 2.41B | |
+16.88% | 2.39B | |
-29.25% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- ASMB Stock
- Stock
- Company Ventrus Biosciences Inc